Gantzert Investment Company’s Bristol-Myers Squibb BMY Stock Holding History

Gantzert Investment Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$30K	Hold	500	–	–	0.03%	46
2020 Q2	$29K	Hold	500	–	–	0.03%	45
2020 Q1	$28K	Hold	500	–	–	0.03%	45
2019 Q4	$32K	Hold	500	–	–	0.03%	47
2019 Q3	$25K	Sell	500 -244	-33%	-$11.5K	0.02%	50
2019 Q2	$34K	Hold	744	–	–	0.03%	51
2019 Q1	$35K	Hold	744	–	–	0.04%	44
2018 Q4	$39K	Buy	+744	New	+$40K	0.04%	43

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Gantzert Investment Company's BMY Position: Q3 2020 in Review

Gantzert Investment Company held its Bristol-Myers Squibb (BMY) position steady in Q3 2020 at 500 shares worth $30K. The position accounts for 0.03% of the portfolio, ranked #46.

Gantzert Investment Company first reported a position in BMY in Q4 2018 and has held it in 8 quarters since. The position peaked at $39K in Q4 2018. 2,215 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

Gantzert Investment Company held 500 shares of Bristol-Myers Squibb worth $30K as of Q3 2020.
Gantzert Investment Company left its Bristol-Myers Squibb share count unchanged in Q3 2020.
Bristol-Myers Squibb made up 0.03% of Gantzert Investment Company's portfolio in Q3 2020, its #46 holding.
Gantzert Investment Company first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 8 quarters since.
Gantzert Investment Company's Bristol-Myers Squibb position peaked at $39K in Q4 2018.
2,215 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on Gantzert Investment Company's 13F filing for Q3 2020, filed 7 Oct 2020.